Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is sublingual immunotherapy clinically effective?

Hans-Jørgen Malling1

  • 1Allergy Clinic, National University Hospital, Copenhagen, Denmark. all-unit@rh.dk

Current Opinion in Allergy and Clinical Immunology
|January 31, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Hymenoptera venom allergy].

Ugeskrift for laeger·2025
Same author

ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy.

Clinical and translational allergy·2021
Same author

[Anaphylaxis in children and adults].

Ugeskrift for laeger·2020
Same author

2019 ARIA Care pathways for allergen immunotherapy.

Allergy·2019
Same author

Proficiency testing of skin prick testers as part of a quality assurance system.

Clinical and translational allergy·2016
Same author

[Anaphylaxis].

Ugeskrift for laeger·2015

Sublingual immunotherapy (SLIT) shows mixed results, with many studies lacking robust design. More evidence is needed to confirm its effectiveness for routine allergy treatment.

Area of Science:

  • Allergy and Immunology
  • Clinical Pharmacology
  • Evidence-Based Medicine

Background:

  • Sublingual immunotherapy (SLIT) is increasingly utilized for treating allergic conditions.
  • The adoption of SLIT varies globally, with some regions favoring it over subcutaneous immunotherapy.
  • Rigorous evaluation of clinical efficacy is crucial for widespread, unrestricted use of SLIT.

Purpose of the Study:

  • To critically analyze placebo-controlled, double-blind studies on sublingual immunotherapy.
  • To assess the clinical efficacy of SLIT based on symptom/medication scores.
  • To determine the proportion of studies demonstrating statistically significant and clinically relevant reductions in disease severity.

Main Methods:

  • Systematic review of placebo-controlled, double-blind studies.

Related Experiment Videos

  • Inclusion criteria focused on studies reporting symptom and medication scores for primary outcomes.
  • Analysis of 23 studies meeting the evaluation criteria.

    • Main Results:

    • Only 26% of reviewed studies were categorized as unequivocally effective.
    • 35% of studies showed possible effectiveness, with improvements in either symptom or medication scores.
    • A significant proportion (39%) of studies demonstrated no statistically documented efficacy for SLIT.

    Conclusions:

    • Many studies on SLIT suffer from inadequate study designs, contributing to inconclusive or negative findings.
    • Further high-quality research is required to establish the beneficial efficacy of sublingual immunotherapy.
    • Current evidence is insufficient to recommend SLIT as a routine treatment without additional documentation.